Abstract: This application relates to omniphobic materials which are physically and chemically modified at their surface to create hierarchically structured materials with both nanoscale and microscale structures that provide the omniphobic properties. Methods of making such omniphobic surfaces with hierarchical structures and uses thereof, including as flexible films that repel contaminants are also disclosed in the application.

Abstract: In one aspect the invention provides a method for distinguishing between a viral-only infection of the upper respiratory tract or a bacterial or viral/bacterial coinfection in a patient by analyzing a respiratory sample.

Abstract: The disclosure belongs to the field of micro-nano electronic materials, and in particular to a Se-based selector material, a selector unit, and a preparation method thereof. The Se-based selector material is a compound including Ge, Se, and B elements. The chemical formula of the Se-based selector material is (GexSe1?x)1?yByMz, in which the M element is at least one of In, Ga, Al, and Zn, and 0.1?x?0.9, 0.02?y?0.15, and 0?z?0.2. The problems of safety and stability of the existing material selection for the selector are solved by the selector material, the selector unit, and the preparation method thereof provided by the disclosure. In addition, the threshold voltage of the selector device prepared based on the Se-based selector material is adjustable, and the comprehensive performance is good.

Abstract: The disclosure provides a non-human transgenic animal having at least one CREBBP gene locus into which a mutation has been introduced, wherein the mutated CREBBP gene encodes a mutant CREBBP consisting of an amino acid sequence having at least 90% identity with the amino acid sequence of SEQ ID NO: 5. The disclosure also provides a method of producing the transgenic animal comprising introducing a mutation into at least one CREBBP gene locus of a non-human animal. The disclosure further provides use of the transgenic animal as a model of Rubinstein-Taybi syndrome or advanced sleep phase syndrome.

Abstract: Disclosed is a network hypervisor apparatus for providing a software defined networking (SDN)-based virtual network, the network hypervisor apparatus including a data collector configured to collect control traffic data and network topology information for each virtual switch; a control traffic predictor configured to predict future control traffic based on the control traffic data and the network topology information; and a translator configured to translate a control message corresponding to a virtual switch based on a prediction result.

Abstract: A motor device includes a stator assembly including a first magnetic coil including first windings wound around an outer face and an inner face of a first support and in a central-axis direction thereof; and a second magnetic coil including second windings wound around a surface of a second support inside or outside the first support and in a circumferential direction thereof; and a rotor assembly including a plurality of first permanent magnets; and a plurality of second permanent magnets including first and second extending magnets magnetized in an opposite direction to a magnetized direction of the first permanent magnets, wherein each of the first and second extending magnets has a length greater than each of the first permanent magnets, wherein the first and second extending magnets are respectively disposed in a first end area and a second end area opposite to each other of the rotor assembly.

Abstract: An apparatus for sensing a target analyte includes a sensing material of a baseline composition. The sensing material is in electrical communication with an alternating energy input across the sensing material at a first frequency. The sensing material is configured to be placed within an environment such that an exposed state is in communication with a concentration of a target analyte proximate the sensing material, and wherein the target analyte changes at least one compositional property of the baseline composition. An impedance detection device is connected to a sensing circuit and receives an output from the sensing material, the output exhibiting a respective impedance value of the sensing material corresponding to the input for the first frequency. The respective impedance value is dependent upon the concentration of the target analyte in the environment and the first frequency.

Abstract: The present disclosure relates to TM4SF5-specific humanized antibodies and uses thereof.

Abstract: The present invention provides an on-chip integrated cell phone spectrometer and a cell phone. The spectrometer includes: a detection system, including a cell phone lens and a focal plane detector integrated with a Bayer filter; and a spectral filter array, integrated at an edge of the Bayer filter, the spectral filter array including a plurality of filtering channels with different spectral transmittances, each filtering channel corresponding to one or more detector pixels, where the cell phone lens is configured to acquire a reflected light from an object under test, the focal plane detector is configured to acquire an intensity signal of the reflected light, and after different intensity signals corresponding to different filtering channels are obtained, a data processing system performs spectral reconstruction to obtain spectral data of the object under test.

Abstract: A pharmaceutical composition is provided that comprises an effective amount of dillapiole or a derivative thereof, and a pharmaceutically-acceptable vehicle, carrier, or excipient. Methods of treating a bacterial infection are also described and include administering an effective amount of dillapiole or a derivative thereof to a subject in need of such treatment. Methods of reducing bacterial virulence are further described and include contacting a bacterium, such as a F. tularensis or A. baumannii bacterium, with an effective amount of dillapiole or a derivative thereof.

Abstract: A device, method, and non-transitory computer readable medium are described. The method includes receiving a dataset including hand written Arabic words and hand written Arabic alphabets from one or more users. The method further includes removing whitespace around alphabets in the hand written Arabic words and the hand written Arabic alphabets in the dataset. The method further includes splitting the dataset into a training set, a validation set, and a test set. The method further includes classifying one or more user datasets from the training set, the validation set, and the test set. The method further includes identifying the target user from the one or more user datasets. The identification of the target user includes a verification accuracy of the hand written Arabic words being larger than a verification accuracy threshold value.

Abstract: Disclosed herein include recombinant terminal deoxynucleotidyl transferases (TdTs). In some embodiments, the recombinant TdT comprises an amino acid sequence that is at least 80% identical to a bovine TdT, wherein the recombinant TdT comprises one or more amino acid substitution mutations at one or more positions functionally equivalent to Glu191, Lys193, Glu194, Asp242, Lys287, Phe296, Met299, Thr342, and His421 in the bovine TdT.

Abstract: An inorganic adhesive includes magnesium oxide, magnesium sulfate heptahydrate, silica fume, silica sol, lithium silicate, sodium silicate, citric acid, microcrystalline cellulose, cellulose nanowhiskers, amino trimethylene phosphonic acid, and water.

Abstract: A surface protection composition contains (a) a phosphorus compound represented by formula (1), wherein R1 represents a hydrogen atom, R2 represents a hydrocarbon group having 4 to 30 carbon atoms, and R3 represents a hydrogen atom or a hydrocarbon group having 4 to 30 carbon atoms, (b-1) a metal-containing compound or (b-2) an amine compound, (c) a (meth)acrylate having a hydrocarbon chain having 4 or more carbon atoms, (d-1) an acylphosphine oxide photopolymerization initiator and (d-2) an ?-aminoacetophenone photopolymerization initiator, wherein the composition has the compound (d-1) in an amount of 0.1 to 3.0 mass % with respect to the total amount of the composition, compound (d-2) in an amount of 0.1 to 3.0 mass % with respect to the total amount of the composition and a total amount of the compound (d-I) and (d-2) is less than 5.0 mass % with respect to the total amount of the composition.

Abstract: Various embodiments comprise systems, methods, architectures, mechanisms and apparatus for undersea transmission using a Zero-Correlation-Zone (ZCZ) signal with an auto-correlation function having a zero-sidelobe zone, wherein modulated data is mapped to circular time shifts in ZCZ signals for transmission, and wherein periodic cross-correlation function peaks of received ZCZ signals are detected to enable thereby recovery of the circular time shifts in the received ZCZ signals in the time domain.

Abstract: Disclosed are a metal catalyst with a vertical heterojunction interface and a method of producing the same. The metal catalyst with the vertical heterojunction interface according to an embodiment of the disclosure allows hydrogen adsorbed on a transition metal oxide to be transferred to a transition metal sulfide (hydrogen spillover phenomenon), thereby having effects on having both excellent hydrogen adsorption performance and excellent catalyst activities.

Abstract: In an embodiment, the present disclosure pertains to a medical device. In some embodiments, the medical device includes a first compartmentalized microfluidic channel flanked by two microchannels and a second compartmentalized microfluidic channel. In some embodiments, the first and second compartmentalized microfluidic channels are situated vertically one to another. In some embodiments, the medical device further includes a porous membrane situated between the first and second compartmentalized microfluidic channels. In another embodiment, the present disclosure pertains to an organ-on-chip. In some embodiments, the organ-on-chip includes a top portion having three parallel microchannels. In some embodiments, the three parallel microchannels are separated by micropillars. In some embodiments, the organ-on-chip further includes a bottom portion having a fourth microchannel and a membrane between the top portion and the bottom portion.

Abstract: The present invention provides a means whereby it is possible to clarify the mechanism of manifestation of symptoms, an illness, or dysfunction caused by mitochondrial dysfunction and prevent or treat symptoms, an illness, or dysfunction relating to the same mechanism of manifestation. One embodiment of the present invention relates to a ferroptosis inhibitor containing a compound represented by formula (I), a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof as an active ingredient. Another embodiment of the present invention relates to a medicine that contains the ferroptosis inhibitor as an active ingredient and is for use in the prevention or treatment of symptoms, an illness, or dysfunction relating to ferroptosis. Yet another embodiment of the present invention relates to a compound represented by formula (I-1), a salt thereof, or a solvate thereof.

Abstract: Provided is a sulfide solid electrolyte that has a novel crystal structure and exhibits an ionic conductivity, the sulfide solid electrolyte containing a lithium atom, a phosphorus atom, a sulfur atom, and at least one kind of halogen atom selected from a chlorine atom and a bromine atom, and having a specific diffraction peak in powdery X-ray diffractometry using CuK? line, and a method for producing a sulfide solid electrolyte, the method including mixing a solvent 1 having a heteroatom and a raw material 1 containing specific atoms to prepare a mixture, preparing a solution that contains a raw material 2 containing a halogen atom and a solvent 2 having a heteroatom, mixing the mixture and the solution to prepare a fluid, and heating the fluid.

Abstract: An electrocardiograph (ECG) signal enhancement method based on a novel generative adversarial network (GAN) effectively enhances a capability of a generator model for understanding and expressing input data by using a multi-branch structure of bi-directional long short-term memory (BiLSTM) neural networks with different quantities of hidden neurons, and stitching outputs of last time steps of forward propagation of the different BiLSTM networks. A new ECG signal enhancement module EEA-Net is proposed, which uses an adaptive convolutional layer to dynamically adjust a size of a convolution kernel, making the model more flexible in processing input sequences of different lengths. In addition, the model uses an adaptive average pooling layer to perform weighted average pooling on the input data to better capture important information of the input data.